MoleculeDx, Inc. is a molecular diagnostics company advancing research-driven approaches to cancer detection. Its scientific platform is grounded in more than a decade of peer-reviewed research on cancer-associated fusion genes and fusion transcripts. Through Fusion-detect Technology, MoleculeDx focuses on multi-marker molecular analysis and the study of circulating fusion-transcript signals, supporting evidence-based research in hepatocellular carcinoma and other areas of cancer science.
-
3 Articles
-
2 Photos
-
0 Vidéos
-
Habitant Pennsylvania
-
Male
-
06/03/1969
-
Suivi par 0 membre
Rechercher
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
Mises à jour récentes
-
Liver Cancer Screening Blood Test | MoleculeDx, Inc.
Explore MoleculeDx, Inc. liver cancer screening blood test research, analyzing cancer-associated fusion-transcript signals through a multi-marker molecular approach. Peer-reviewed HCC studies have evaluated circulating cell-free fusion transcripts and machine-learning models to support liver cancer risk assessment research.
For more visit - https://www.moleculedx.com/blood-test-for-liver-cancer/Liver Cancer Screening Blood Test | MoleculeDx, Inc. Explore MoleculeDx, Inc. liver cancer screening blood test research, analyzing cancer-associated fusion-transcript signals through a multi-marker molecular approach. Peer-reviewed HCC studies have evaluated circulating cell-free fusion transcripts and machine-learning models to support liver cancer risk assessment research. For more visit - https://www.moleculedx.com/blood-test-for-liver-cancer/0 Commentaires 0 Parts 94 Vue 0 Aperçu
Plus de lecture
